sitagliptin and acarbose

DRUG2 trials

Sponsors

Wuhan General Hospital of Guangzhou Military Command, Nanjing First Hospital, Nanjing Medical University

Conditions

Coronary Artery DiseaseNewly Diagnosed Type 2 DiabetesType 2 Diabetes

Phase 4

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

CompletedNCT01863147

Wuhan General Hospital of Guangzhou Military CommandCoronary Artery Disease, Newly Diagnosed Type 2 Diabetes

Start: 2013-07-31End: 2015-07-31Updated: 2015-08-18

Unknown Phase

Comparison of the FGM Profiles in Patients of Type 2 Diabetes Treated With Sitagliptin and Acarbose

CompletedNCT05035849

Nanjing First Hospital, Nanjing Medical UniversityType 2 Diabetes

Start: 2020-01-30End: 2021-05-05Updated: 2021-09-05